Filing Details

Accession Number:
0000950170-25-011311
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-01-30 21:02:57
Reporting Period:
2025-01-28
Accepted Time:
2025-01-30 21:02:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1812364 Relay Therapeutics Inc. RLAY () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1636994 Brian Adams C/O Relay Therapeutics, Inc.
399 Binney Street, 2Nd Floor
Cambridge MA 02142
Chief Legal Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-01-28 33,688 $4.63 287,920 No 4 S Direct
Common Stock Acquisiton 2025-01-28 139,141 $0.00 427,061 No 4 A Direct
Common Stock Disposition 2025-01-30 20,791 $4.42 406,270 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 A Direct
No 4 S Direct
Footnotes
  1. Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 105,505 shares of restricted stock units ("RSUs") on January 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
  2. Includes 171,828 shares underlying RSUs.
  3. Represents RSUs granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  4. Includes 310,969 shares underlying RSUs.
  5. Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 69,570 shares of RSUs on January 29, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
  6. Includes 241,399 shares underlying RSUs.